Feature | No rhG-CSF (n = 61) | rhG-CSF (n = 246) | P value |
---|---|---|---|
Age, y | 56.52 ± 10.22 | 57.74 ± 8.13 | 0.25 |
Weight, Kg | 60.85 ± 10.80 | 59.40 ± 9.51 | 0.30 |
Gender, n (%) | Â | Â | 0.97 |
 Male | 46 (75.41%) | 186 (75.61%) |  |
 Female | 15 (24.59%) | 60 (24.39%) |  |
Smoking, n (%) | Â | Â | 0.96 |
 Never | 24 (39.34%) | 96 (39.02%) |  |
 Former/current | 37 (60.66%) | 150 (60.98%) |  |
Histopathology, n (%) | Â | Â | 0.96 |
 Adenocarcinoma | 29 (47.54%) | 122 (49.59%) |  |
 Squamous carcinoma | 29 (47.54%) | 112 (45.53%) |  |
 Othersa | 3 (4.92%) | 12 (4.88%) |  |
Differentiation, n (%) | Â | Â | 0.32 |
 I | 2 (3.28%) | 7 (2.85%) |  |
 II | 7 (11.48%) | 52 (21.14%) |  |
 III | 7 (11.48%) | 33 (13.41%) |  |
 NA | 45 (73.77%) | 154 (62.60%) |  |
Clinical stage, n (%) | Â | Â | 0.152 |
 IB | 17 (27.87%) | 43 (17.48%) |  |
 IIA | 2 (3.28%) | 14 (5.69%) |  |
 IIB | 28 (45.90%) | 97 (39.43%) |  |
 IIIA | 12 (19.67%) | 78 (31.71%) |  |
 IIIB | 2 (3.28%) | 14 (5.69%) |  |
Chemotherapy, n (%) | Â | Â | 0.24 |
 Taxane+Platinum | 28 (45.90%) | 101 (41.06%) |  |
 Gemcitabine+Platinum | 10 (16.39%) | 55 (22.36%) |  |
 Pemetrexed+Platinum | 21 (34.43%) | 87 (35.37%) |  |
 Taxane | 1 (1.64%) | 1 (0.41%) |  |
 Pemetrexed | 1 (1.64%) | 0 (0.00%) |  |
 Othersb | 0 (0.00%) | 2 (0.81%) |  |
No. of chemotherapy, n (%) | Â | Â | 0.01 |
 < 4 | 28 (45.90%) | 72 (29.27%) |  |
 ≥ 4 | 33 (54.10%) | 174 (70.73%) |  |
Myelosuppression, n (%) |  |  | < 0.001 |
 0 | 56 (91.80%) | 107 (43.50%) |  |
 1 | 2 (3.28%) | 55 (22.36%) |  |
 2 | 2 (3.28%) | 49 (19.92%) |  |
 3 | 0 (0.00%) | 20 (8.13%) |  |
 4 | 1 (1.64%) | 15 (6.10%) |  |
Fever, n (%) | Â | Â | 0.30 |
 No | 58 (95.08%) | 224 (91.06%) |  |
 Yes | 3 (4.92%) | 22 (8.94%) |  |
Antibiotic, n (%) | Â | Â | 0.64 |
 No | 56 (91.80%) | 221 (89.84%) |  |
 Yes | 5 (8.20%) | 25 (10.16%) |  |
Complications, n (%) | Â | Â | 0.90 |
 No | 40 (65.57%) | 167 (67.89%) |  |
 Hypertension | 9 (14.75%) | 31 (12.60%) |  |
 Tuberculosis | 2 (3.28%) | 5 (2.03%) |  |
 Gastritis/Ulcers | 3 (4.92%) | 14 (5.69%) |  |
 Hepatitis | 0 (0.00%) | 9 (3.66%) |  |
 Diabetes | 1 (1.64%) | 5 (2.03%) |  |
 Gallbladder disease | 2 (3.28%) | 3 (1.22%) |  |
 Enteropatia | 1 (1.64%) | 2 (0.81%) |  |
 Thyroid disease | 1 (1.64%) | 3 (1.22%) |  |
 Coronary heart disease | 1 (1.64%) | 2 (0.81%) |  |
 Chronic bronchitis/COPD | 1 (1.64%) | 5 (2.03%) |  |